Notice of Public Consultation on Shenzhen Tobacco Monopoly Bureau (Draft)

Jan.14.2025
Notice of Public Consultation on Shenzhen Tobacco Monopoly Bureau (Draft)
Shenzhen Tobacco Monopoly Bureau solicits public opinion on administrative punishment regulations, receiving 2 suggestions and making amendments.

On December 18, 2024, the Shenzhen Tobacco Monopoly Bureau announced on its government website the solicitation of opinions on the "Implementation Measures for Administrative Penalty Discretion of the Shenzhen Tobacco Monopoly Bureau (Draft for Soliciting Opinions)." The announcement openly requested suggestions from the public, and a total of 2 opinions were received within the specified deadline. After carefully analyzing and studying each opinion, the bureau will now explain the adopted opinions as follows:


Regarding Article 22, some opinions suggest that administrative penalties that are currently undergoing administrative reconsideration or administrative litigation, or have already been decided upon by the reconsideration authority or court, should not be ordered to be corrected. Therefore, the phrase "should be ordered to correct" in Article 22 of the draft for comments should be modified to "should be ordered to correct in accordance with the law" in order to guide and supervise the exercise of discretion in administrative penalties by the Shenzhen Tobacco Monopoly Bureau and correct any inappropriate penalty actions that are found.


The opinion is legally valid and reasonable, and will be adopted.


Regarding Appendix 1, some opinions point out that in items 24 to 29 of the "solicitation draft" in Appendix 1, "e-cigarette" is specified under "tobacco," but in items 2 to 13 and 15 to 22, "tobacco" does not specify "e-cigarette." The inconsistency in the text can easily lead to misunderstandings. Also, according to relevant laws, regulations, and normative documents related to e-cigarettes, it is believed that the penalties in Appendix 1 of the "solicitation draft" should include penalties for e-cigarettes.


After conducting research, the opinion was not accepted for the following reasons:


According to Article 17 of the Law of the People's Republic of China on the Protection of Minors, parents or other guardians of minors are not allowed to engage in the following behaviors: (4) Allowing or inciting minors to smoke (including e-cigarettes, the same below), drink alcohol, gamble, beg or bully others. Therefore, Appendix 1 of the draft for soliciting opinions specifically clarifies the scope of "smoking" in items 24 to 29, in order to fully implement the provisions of the Law on the Protection of Minors of the People's Republic of China. In addition, other illegal activities involving e-cigarettes are not the focus of this draft for soliciting opinions.


This is to announce.


Shenzhen Tobacco Monopoly Bureau


January 14, 2025


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Supreme Vape Revenue Rises 15% Despite UK Disposable Vape Ban
Supreme Vape Revenue Rises 15% Despite UK Disposable Vape Ban
UK consumer goods group Supreme said its vaping revenue rose 15% to £148.1 million in the year to March 31, 2026, despite the UK disposable vape ban taking effect during the period, while the company identified the Vaping Products Duty due in October as the next major industry milestone.
Regulations
Jul.03 by 2Firsts Perspectives
Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
A new Swedish study found oral mucosal lesions in 79% of examined nicotine pouch users and 89% of tobacco-derived snus users, with different tissue-response patterns between the two categories. For manufacturers and regulators, the findings shift attention toward product formulation, flavouring, pouch materials and local oral exposure, not only whether a product contains tobacco. The study found no higher prevalence of caries or periodontal disease, but it could not establish causality, long-term outcomes or differences between individual products or designs.
Special Report
Jul.27
FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
The U.S. Food and Drug Administration (FDA) has issued modified risk granted orders to Swedish Match USA for 20 ZYN nicotine pouch products, allowing the already-authorized products to be marketed with a specific claim that using ZYN instead of cigarettes lowers the risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis.
Jul.01
Reemtsma says German illegal e-cigarette seizures reached 70% of 2025 total, pouches 179%
Reemtsma says German illegal e-cigarette seizures reached 70% of 2025 total, pouches 179%
Reemtsma said its first-half 2026 black-market tracker for tobacco and nicotine products showed a continued rise in officially reported seizures in Germany, with illegal e-cigarette seizures reaching 70% of the full-year 2025 level and snus and nicotine pouch seizures reaching 179% of last year’s total.
Jul.08
China Discloses First Criminal Case Over Counterfeit Vapes Disguised as “Medical Nebulizers” and “Zero-Nicotine” Products
China Discloses First Criminal Case Over Counterfeit Vapes Disguised as “Medical Nebulizers” and “Zero-Nicotine” Products
Chinese authorities have disclosed the country’s first reported criminal case involving counterfeit vapes marketed as “medical nebulizers” and “zero-nicotine” products. Authorities determined that the products involved were counterfeit vapes and pursued criminal charges for producing and selling counterfeit goods. According to the report, the case resulted in the seizure of 347,000 counterfeit vape pods and 53,700 vape devices, with physical goods valued at 22.13 million yuan.
Aug.04
From Nicotine Salts to Cocrystals: China’s Shenzhen Huabao institute explores a more stable form for sustained nicotine release
From Nicotine Salts to Cocrystals: China’s Shenzhen Huabao institute explores a more stable form for sustained nicotine release
China-based Shenzhen Huabao Collaborative Innovation Technology Research Institute Co., Ltd. has filed a patent application for a nicotine-ascorbic acid cocrystal, exploring a new solid-state form of nicotine. The patent proposes applications across e-liquids, heated tobacco sticks, oral tobacco, chewing tobacco and snuff. In nicotine pouch tests disclosed in the filing, cocrystal formulations showed less than a 6% decline in nicotine content after three months of accelerated storage and a release profile combining early-stage release with sustained delivery over 60 minutes. The filing reflects exploration of nicotine forms beyond conventional nicotine base and nicotine salts.
Aug.13